Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Return on Assets (2021 - 2025)

Bolt Biotherapeutics' Return on Assets history spans 5 years, with the latest figure at 0.61% for Q3 2025.

  • For Q3 2025, Return on Assets fell 1.0% year-over-year to 0.61%; the TTM value through Sep 2025 reached 0.61%, down 1.0%, while the annual FY2024 figure was 0.52%, 17.0% down from the prior year.
  • Return on Assets for Q3 2025 was 0.61% at Bolt Biotherapeutics, up from 0.63% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.21% in Q2 2021 and bottomed at 0.68% in Q1 2025.
  • The 5-year median for Return on Assets is 0.39% (2023), against an average of 0.43%.
  • The largest annual shift saw Return on Assets dropped -1bps in 2022 before it decreased -24bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.29% in 2021, then fell by -29bps to 0.37% in 2022, then dropped by -11bps to 0.41% in 2023, then tumbled by -57bps to 0.65% in 2024, then grew by 6bps to 0.61% in 2025.
  • Per Business Quant, the three most recent readings for BOLT's Return on Assets are 0.61% (Q3 2025), 0.63% (Q2 2025), and 0.68% (Q1 2025).